Placebo metered-dose inhaler

COMBINATION_PRODUCT2 trials

Sponsors

Bond Avillion 2 Development LP, AstraZeneca

Conditions

Asthma, Exercise-InducedExercise Induced Bronchospasm

Phase 3

A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma

CompletedNCT04234464

Bond Avillion 2 Development LPExercise Induced Bronchospasm

Start: 2020-01-15End: 2020-08-28Updated: 2022-01-13

A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma

CompletedNCT06245551

AstraZenecaAsthma, Exercise-Induced

Start: 2023-12-22End: 2024-06-29Updated: 2025-08-27

Related Papers

Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: The TYREE study.

2021-10-244 citations

Phase III Evaluation of the Efficacy and Safety of PT027 (Budesonide/Albuterol pMDI) Compared to Placebo pMDI on Exercise-Induced Bronchoconstriction in Adult and Adolescent Subjects with Asthma: the TYREE Study

2021-05-01